Overview

Effect of Pre-Treatment With Cromolyn or Albuterol on Response to PUL-042 Inhalation Solution (PUL-042)

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study evaluates the effect of pre-treatment with either cromolyn sodium or albuterol sulfate on the safety and tolerability or PUL-042 Inhalation Solution in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Pulmotect, Inc.
Collaborator:
WCCT Global
Treatments:
Albuterol
Cromolyn Sodium
Pam2CSK4 acetate and ODN M362 combination
Pharmaceutical Solutions